Qing Li
- Molecular Biology top 2%
- Cancer Research top 1%
- Epidemiology top 5%
- Oncology top 5%
- Immunology top 10%
- Topics
- Liver Disease Diagnosis and Treatment (22 papers)Cancer-related molecular mechanisms research (20 papers)RNA modifications and cancer (16 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Qing Li
158 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Molecular Biology 2.7k
- Cancer Research 1.1k
- Epidemiology 777
- Oncology 711
- Immunology 425
Countries citing papers authored by Qing Li
This map shows the geographic impact of Qing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Li more than expected).
Fields of papers citing papers by Qing Li
This network shows the impact of papers produced by Qing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Li. The network helps show where Qing Li may publish in the future.
Co-authorship network of co-authors of Qing Li
This figure shows the co-authorship network connecting the top 25 collaborators of Qing Li. A scholar is included among the top collaborators of Qing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Li. Qing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 8 | |
| 9 | 1 | |
| 10 | 6 | |
| 11 | 34 | |
| 12 | 10 | |
| 13 | 3 | |
| 14 | 1 | |
| 15 | 9 | |
| 16 | 2 | |
| 17 | 7 | |
| 18 | 17 | |
| 19 | EFFECT OF TILDRAKIZUMAB ON PERSONAL RELATIONSHIPS IN PATIENTS WITH MODERATE-TO-SEVERE CHRONIC PLAQUE PSORIASIS | 1 |
| 20 | 20 |
About Qing Li
Qing Li is a scholar working on Cancer Research, Hepatology and Epidemiology, having authored 169 papers that have together received 4.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Cancer-related molecular mechanisms research (20 papers) and RNA modifications and cancer (16 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.7k citations) and Biological Psychiatry (79 citations). Qing Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jun Yu, Winnie Fong, Zhikui Liu, Qingguang Liu, Kangsheng Tu, Yufeng Wang, Jiao Wu, Xiangsheng Fu, Bowen Yao and Cong Wang. Their work appears in journals such as Journal of Clinical Oncology, Bioinformatics and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.